KARYOPHARM THERAPEUTICS INC
KPTI·48576U205·US·Common Stock·Healthcare - Biotechnology-13D/G
KPTI (KARYOPHARM THERAPEUTICS INC) is held by 44 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($10.7M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($10.1M), GOLDMAN SACHS GROUP INC ($5.3M). Net institutional sentiment: Bullish.
44
Holders
(1 Elite)
$47.8M
Total Value
74% (46)
Consensus
34 buying - 12 selling
13F: Insider & Congress:
Who's Trading
ActivistTRT. Rowe Price Investment Management, Inc.6.6%Jun 5, 2026
ActivistIKIkarian Capital, LLC0.0%May 15, 2026
InsiderPSPoulton StuartSell $4KMay 14, 2026
InsiderMMMano MichaelSell $3KMay 14, 2026
ActivistAAAffinity Asset Advisors, LLC8.6%May 14, 2026
ActivistADAdage Capital Management, L.P.8.1%May 13, 2026
InsiderRRRangwala ReshmaSell $4KApr 21, 2026
InsiderPAPaulson Richard A.Sell $116KMar 2, 2026
Top Holders
Showing 1-20 of 51
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $666.6B
413 holders · $186.3B
394 holders · $391.3B
392 holders · $97B
391 holders · $123.5B
391 holders · $147B
389 holders · $76.8B
385 holders · $208.9B
381 holders · $254.9B
380 holders · $129.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer